The recipient was Tim Andrews, a 66-year-old New Hampshire resident who had end-stage kidney disease and was on dialysis for ...

The second person ever has received a transplant with a genetically modified pig kidney.

FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...

Massachusetts General Hospital announced Friday that Tim Andrews recovered well enough after the Jan. 25 transplant to leave ...

On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...

It was the fourth pig kidney transplant in the United States, and the first of three that will be done at Mass General as part of a new clinical trial sanctioned by the Food and Drug Administration.

For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...

For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...

Massachusetts General Hospital has performed its second successful genetically edited pig kidney transplant into a patient, MGH reported on Friday. The “miracle” transplant is giving 66-year-old Tim ...

IRVINE, Calif. - Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN), a biotechnology company with a market capitalization of $284.54 million and a remarkable 170% stock return over the past year according to ...